Back to top

Image: Bigstock

ResMed (RMD) Looks Good: Stock Adds 5.7% in Session

Read MoreHide Full Article

ResMed Inc. (RMD - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 9.8% in the past one-month time frame.

The move came after the company reported better-than-expected first-quarter fiscal 2019 results.

The company has seen a mixed track record when it comes to estimate revisions of three increases and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarterremained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ResMed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.  

A better-ranked stock in the Medical - Products industry is Haemonetics Corporation (HAE - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is RMD going up? Or down? Predict to see what others think: Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


ResMed Inc. (RMD) - free report >>

Haemonetics Corporation (HAE) - free report >>

Published in